Skip to main content

Table 2 Molecular prevalence of Bartonella spp and other canine vector borne pathogens

From: Serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in North Carolina

Study group Study population (N) Overall Bartonella spp prevalence N (%) BAPGM diagnostic platform Overall molecular prevalence of other CVBD pathogens N (%) Hemotropic Mycoplasma 16S PCR Ehrlichia/Anaplasma spp PCR SFG Rickettsia PCR Babesia spp PCR
    Pre-enrichment PCR Post-enrichment PCR Isolate      
Group I 47 9 (19%) Bk (3) Bh SA2 (2) 0 3 (6%) Mhc (3) 0 0 0
Bh HI (1) B spp. (2)
B spp. (1)
Group II 50 10 (20%) Bvb III (1) Bvb II (1) Bvb II (8) 3 (6%) Mhc (1) E. ewingii (2) 0 0
Group III 21 2 (10%) Bvb I (1) Bvb I (1)* Bvb I (1)* 4 (19%) Mhc (1) E. ewingii (2) 0 0
    Bvb I (1)*     C Mhp (1)    
  1. Legend: BkBartonella koehlerae; Bh SA2 – Bartonella henselae San Antonio 2; Bh HI– Bartonella henselae Houston 1; BvbBartonella vinsonii subsp berkhoffii genotypes I, II, & III; CVBD – Canine vector borne disease; - Bvb genotype I DNA sequence amplified from serum; * - Bvb genotype I DNA sequence amplified from blood; MhcMycoplasma hemocanis; C Mhp- Candidatus M. hematoparvum; B spp – Bartonella spp; BAPGM – Bartonella Alpha Proteobacteria Growth Medium; PCR – Polymerase chain reaction; SFG – Spotted fever group.